Evaluating the long-term survival benefits of high intensity focused ultrasound ablation for hepatocellular carcinoma with portal vein tumor thrombus: a single center retrospective study

Evaluating the long-term survival benefits of high intensity focused ultrasound ablation for hepatocellular carcinoma with portal vein tumor thrombus: a single center retrospective study

Aims To evaluate the long-term survival benefits of high intensity focused ultrasound (HIFU) ablation in patients with hepatocellular carcinoma (HCC) combined with portal vein tumor thrombus (PVTT).Methods The data of patients with HCC-PVTT treated with HIFU from January 2014 to December 2019 were r...

Full description

Bibliographic Details
Main Authors:	Xing Chen, Yuhong Ma, Jun Zhang, Wei Yang, Chengbing Jin, Lifeng Ran, Hui Zhu, Jin Bai, Kun Zhou
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Series:	International Journal of Hyperthermia
Subjects:	Hepatocellular carcinoma portal vein tumor thrombus high intensity focused ultrasound ablation survival analysis thermal ablation
Online Access:	https://www.tandfonline.com/doi/10.1080/02656736.2022.2122595

Similar Items

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
by: Xiaodong Song, et al.
Published: (2020-08-01)

Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)
by: Juxian Sun, et al.
Published: (2022-03-01)

Implanting Iodine-125 Seed Strand Inside the Portal Vein Stent: An Improved Approach to Endovascular Brachytherapy for Treatment of Patients with Hepatocellular Carcinoma and Main Portal Vein Tumor Thrombus
by: Zhang L, et al.
Published: (2023-12-01)

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
by: Xiu-Ping Zhang, et al.
Published: (2017-12-01)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
by: Xiaomi Li, et al.
Published: (2023-08-01)

Role of Endoscopic Ultrasound-Guided Fine-Needle Aspiration of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
by: Dina Eskandere, et al.
Published: (2021-09-01)

Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence
by: Li Y, et al.
Published: (2024-07-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
by: Aoran Dong, et al.
Published: (2023-12-01)

Right hepatectomy with thrombectomy in treatment of hepatocellular carcinoma with portal vein thrombosis: A case report
by: Mohammad Saief Uddin, et al.
Published: (2023-12-01)

The “Hand as Foot” teaching method in classification of interventional radiology for portal-vein tumor thrombus from hepatocellular carcinoma: A clinical experience
by: Manlu Wang, et al.
Published: (2022-08-01)

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis
by: Jen-Fu Yang, et al.
Published: (2019-10-01)

Downstaging and Conversation Strategy for Advanced Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus: TACE, 125I Seed Implantation, and RFA for Hepatocellular Carcinoma with Portal Vein Branch Tumor Thrombus
by: Zhao XH, et al.
Published: (2023-02-01)

Transileocolic Vein Obliteration for Bleeding Rectal Varices with Portal Thrombus
by: Hirotaka Arai, et al.
Published: (2013-03-01)

PD-1 combined with lenvatinib and TACE for the transformational treatment of hepatocellular carcinoma combined with portal vein tumor thrombus: a case report and literature review
by: Sheng Liu, et al.
Published: (2023-10-01)

Surgical management in hepatocellular carcinoma with portal vein tumour thrombosis: is this the end of the road or a chance to expand the criteria for resectability?
by: Nikolaos Benatatos, et al.
Published: (2022-07-01)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
by: Lv WF, et al.
Published: (2018-10-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
by: Moon Haeng Hur, et al.
Published: (2023-07-01)

Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
by: Li X, et al.
Published: (2025-01-01)

Ultrasound Guided Fine-Needle Aspiration Cytology (FNAC) of Portal Vein Thrombus: A Novel Diagnostic and Staging Technique for Occult Hepatocellular Carcinoma
by: Sukumar Ramaswami, et al.
Published: (2014-04-01)

Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event
by: Oladapo Adaramola, MD, et al.
Published: (2020-08-01)

Long-term surgical outcomes of bile duct tumor thrombus versus portal vein tumor thrombus for hepatocellular carcinoma: a propensity score matching analysis
by: Yi-Nan Li, et al.
Published: (2024-04-01)

Survival benefit of neoadjuvant hepatic arterial infusion chemotherapy followed by hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
by: Zili Hu, et al.
Published: (2023-09-01)

Distant survival for patients undergoing surgery using volatile versus IV anesthesia for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study
by: Xiao-Yan Meng, et al.
Published: (2020-09-01)

Postoperative adjuvant aspirin for patients with hepatitis B virus-related hepatocellular carcinoma and portal vein tumor thrombus: An open-label, randomized controlled trial
by: Chong-De Lu, et al.
Published: (2023-09-01)

Left ventricular thrombus following radiofrequency ventricular tachycardia ablation
by: Seth Fakess, DO, et al.
Published: (2022-06-01)

Endovascular brachytherapy with iodine-125 seed strand for extensive portal vein tumor thrombus in patients with hepatocellular carcinoma
by: Zhongbao Tan, et al.
Published: (2023-07-01)

Fully Covered Stent-TIPS for Advanced HCC Patients with Portal Vein Tumor Thrombus-Related Severe Symptomatic Portal Hypertension
by: Liu Z, et al.
Published: (2025-01-01)

Therapeutic response and risks of radio-frequency in treatment of hepatocellular carcinoma in patients with portal hypertension
by: Medhat Ibraheem Mohammad Ahmad
Published: (2017-12-01)

Curative Effect of Lenvatinib Combined with Locoregional Therapy on PD-L1-positive Hepatocellular Carcinoma Patients with Type Ⅰ-Ⅲ Portal Vein Tumor Thrombus According to Cheng's Classification
by: CHEN Long, et al.
Published: (2022-01-01)

Feasibility and Safety of the Clinical Outcomes of TACE Combined with Lenvatinib and PD-1 Blockades in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Exploratory Study
by: Sun W, et al.
Published: (2024-08-01)

Efficacy and safety of hepatic arterial infusion chemotherapy combined with tyrosine kinase inhibitors and immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk
by: Qi Liu, et al.
Published: (2024-07-01)

Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report
by: Yoshifumi Hidaka, et al.
Published: (2022-07-01)

Intrahepatic hemorrhage and recurrence caused by arterioportal fistula after radiofrequency ablation for hepatocellular carcinoma: A thought-provoking ablation-related complication
by: Li Xu, et al.
Published: (2021-07-01)

Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study
by: Liu G, et al.
Published: (2024-07-01)

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
by: Xia WL, et al.
Published: (2024-09-01)

Case report: Complete response after transcatheter arterial chemoembolization combined with donafenib plus tislelizumab therapy for hepatocellular carcinoma with main trunk portal vein tumor thrombus in a patient coinfected with HIV and HBV
by: Xuhua Xiao, et al.
Published: (2024-07-01)

Growing thrombus adhesion on the left atrial wall after catheter ablation of atrial fibrillation
by: Tetsuma Kawaji, et al.
Published: (2023-06-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
by: Xiao-Hui Zhao, et al.
Published: (2022-10-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
by: Junwei Chen, et al.
Published: (2023-07-01)

Massive portal vein tumor thrombus from colorectal cancer without any metastatic nodules in the liver parenchyma: report of a case
by: Yasushi Rino, et al.
Published: (2011-10-01)